Progesterone as a bone-trophic hormone
- PMID: 2194787
- DOI: 10.1210/edrv-11-2-386
Progesterone as a bone-trophic hormone
Abstract
Experimental, epidemiological, and clinical data indicate that progesterone is active in bone metabolism. Progesterone appears to act directly on bone by engaging an osteoblast receptor or indirectly through competition for a glucocorticoid osteoblast receptor. Progesterone seems to promote bone formation and/or increase bone turnover. It is possible, through estrogen-stimulated increased progesterone binding to the osteoblast receptor, that progesterone plays a role in the coupling of bone resorption with bone formation. A model of the interdependent actions of progesterone and estrogen on appropriately-"ready" cells in each bone multicellular unit can be tied into the integrated secretions of these hormones within the ovulatory cycle. Figure 5 is an illustration of this concept. It shows the phases of the bone remodeling cycle in parallel with temporal changes in gonadal steroids across a stylized ovulatory cycle. Increasing estrogen production before ovulation may reverse the resorption occurring in a "sensitive" bone multicellular unit while gonadal steroid levels are low at the time of menstrual flow. The bone remodeling unit would then be ready to begin a phase of formation as progesterone levels peaked in the midluteal phase. From this perspective, the normal ovulatory cycle looks like a natural bone-activating, coherence cycle. Critical analysis of the reviewed data indicate that progesterone meets the necessary criteria to play a causal role in mineral metabolism. This review provides the preliminary basis for further molecular, genetic, experimental, and clinical investigation of the role(s) of progesterone in bone remodeling. Much further data are needed about the interrelationships between gonadal steroids and the "life cycle" of bone. Feldman et al., however, may have been prophetic when he commented; "If this anti-glucocorticoid effect of progesterone also holds true in bone, then postmenopausal osteoporosis may be, in part, a progesterone deficiency disease."
Similar articles
-
The role of prostaglandins in the regulation of bone metabolism.Clin Orthop Relat Res. 1995 Apr;(313):36-46. Clin Orthop Relat Res. 1995. PMID: 7641496 Review.
-
Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles.Epidemiol Rev. 2014;36:137-47. doi: 10.1093/epirev/mxt012. Epub 2013 Nov 25. Epidemiol Rev. 2014. PMID: 24275546 Review.
-
Mechanisms of sex steroid effects on bone.Biochem Biophys Res Commun. 2005 Mar 18;328(3):688-96. doi: 10.1016/j.bbrc.2004.11.097. Biochem Biophys Res Commun. 2005. PMID: 15694402 Review.
-
Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring.Endocrinology. 1996 May;137(5):2118-25. doi: 10.1210/endo.137.5.8612556. Endocrinology. 1996. PMID: 8612556
-
Cellular and molecular effects of growth hormone and estrogen on human bone cells.APMIS Suppl. 1997;71:1-30. APMIS Suppl. 1997. PMID: 9357492 Review.
Cited by
-
Progesterone and bone: actions promoting bone health in women.J Osteoporos. 2010 Oct 31;2010:845180. doi: 10.4061/2010/845180. J Osteoporos. 2010. PMID: 21052538 Free PMC article.
-
Molecular mechanisms of deer antler in promoting osteogenic differentiation of human mesenchymal stem cells via JUN modulation.Front Immunol. 2025 May 29;16:1550249. doi: 10.3389/fimmu.2025.1550249. eCollection 2025. Front Immunol. 2025. PMID: 40510335 Free PMC article.
-
Effect of the different phases of the menstrual cycle and oral contraceptives on athletic performance.Sports Med. 1993 Dec;16(6):400-30. doi: 10.2165/00007256-199316060-00005. Sports Med. 1993. PMID: 8303141 Review.
-
Depot medroxyprogesterone acetate and osteoporosis. Smoking may explain findings.BMJ. 1994 Mar 12;308(6930):717. BMJ. 1994. PMID: 8179699 Free PMC article. No abstract available.
-
Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ. 1991 Jul 6;303(6793):13-6. doi: 10.1136/bmj.303.6793.13. BMJ. 1991. PMID: 1830502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources